MedTrace Logo

Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction

NCT06484439 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-07-10

No results posted yet for this study

Summary

This is a prospective randomized clinical trial that will investigate which post-operative medications in conjunction with a multimodal analgesia approach can most effectively control post-operative pain and reduce opioid consumption.

Conditions

  • Pain, Post-operative
  • Third Molar
  • Oral Surgery
  • Pain, Acute

Interventions

DRUG

Ketorolac

10 mg PO q 6h scheduled

DRUG

Oxycodone

5 mg PO PRN

DRUG

Acetaminophen

650 mg q 6h scheduled

DRUG

Ibuprofen

600 mg PO scheduled q6h

DRUG

Hydrocodone

5 mg hydrocodone PO PRN q6h

Sponsors & Collaborators

  • United States Naval Medical Center, San Diego

    lead FED

Principal Investigators

  • Patrick T Morrell, DMD · United States Naval Medical Center, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-14
Primary Completion
2021-11-03
Completion
2021-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484439 on ClinicalTrials.gov